TargetProtein tyrosine phosphatase type IVA 2(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 48nMAssay Description:Enzyme activity assays were performed in triplicate in 384-well Greiner Bio-One black small volume microtiter plates, as previously described using r...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 2(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 48nMAssay Description:Table 4: In Vitro Biochemical Analysis of PTP4A Inhibition. Enzyme activity assays were performed in triplicate in 384-well Greiner Bio-One black sma...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 2(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 52nMAssay Description:Inhibition of PTP4A2 (unknown origin) expressed in Escherichia coli assessed as reduction in hydrolysis using DIFMUP as substrate incubated for 30 mi...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 2(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 73.9nMAssay Description:Enzyme activity assays were performed in triplicate in 384-well Greiner Bio-One black small volume microtiter plates, as previously described using r...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 2(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 73.9nMAssay Description:Table 4: In Vitro Biochemical Analysis of PTP4A Inhibition. Enzyme activity assays were performed in triplicate in 384-well Greiner Bio-One black sma...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 2(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 113nMAssay Description:Enzyme activity assays were performed in triplicate in 384-well Greiner Bio-One black small volume microtiter plates, as previously described using r...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 2(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 113nMAssay Description:Table 4: In Vitro Biochemical Analysis of PTP4A Inhibition. Enzyme activity assays were performed in triplicate in 384-well Greiner Bio-One black sma...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 2(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 130nMAssay Description:Inhibition of human His6-tagged PRL-2 expressed in Escherichia coli using TAMRA-Thr-Ala-Asp-Ile-Tyr(PO3H2)-Glu-NH2 peptide as substrate by IMAP-FP as...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 2(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 264nMAssay Description:Enzyme activity assays were performed in triplicate in 384-well Greiner Bio-One black small volume microtiter plates, as previously described using r...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 2(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 264nMAssay Description:Table 4: In Vitro Biochemical Analysis of PTP4A Inhibition. Enzyme activity assays were performed in triplicate in 384-well Greiner Bio-One black sma...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 2(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 277nMAssay Description:Inhibition of human PRL2 expressed in Escherichia coli using TAMRA-Thr-Ala-Asp-Ile-Tyr(PO3H2)-Glu-NH2 substrate by immobilized metal ion affinity-bas...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 2(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 280nMAssay Description:Inhibition of recombinant human His-6-tagged PTP4A2 expressed in Escherichia coli assessed as increase in polarization using TAMRAThr-Ala-Asp-Ile-Tyr...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 2(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 300nMAssay Description:Inhibition of PTP4A2 (unknown origin)More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 2(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 314nMAssay Description:Inhibition of human PTP4A2 by enzyme assayMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 2(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.00E+3nMAssay Description:Enzyme activity assays were performed in triplicate in 384-well Greiner Bio-One black small volume microtiter plates, as previously described using r...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 2(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.00E+3nMAssay Description:Table 4: In Vitro Biochemical Analysis of PTP4A Inhibition. Enzyme activity assays were performed in triplicate in 384-well Greiner Bio-One black sma...More data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 2(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 3.14E+4nMAssay Description:Inhibition of PRL2 (unknown origin) using DiFMUP as fluorogenic phosphate substrate assessed as DiFMUP dephosphorylationMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 2(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 6.94E+4nMAssay Description:Inhibition of PRL2 (unknown origin) using DiFMUP as fluorogenic phosphate substrate assessed as DiFMUP dephosphorylationMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 2(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.04E+5nMAssay Description:Inhibition of PRL2 (unknown origin) using DiFMUP as fluorogenic phosphate substrate assessed as DiFMUP dephosphorylationMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 2(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.04E+5nMAssay Description:Inhibition of PRL2 (unknown origin) using DiFMUP as fluorogenic phosphate substrate assessed as DiFMUP dephosphorylationMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 2(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.09E+5nMAssay Description:Inhibition of PRL2 (unknown origin) using DiFMUP as fluorogenic phosphate substrate assessed as DiFMUP dephosphorylationMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 2(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.50E+5nMAssay Description:Inhibition of PRL2 (unknown origin) using DiFMUP as fluorogenic phosphate substrate assessed as DiFMUP dephosphorylationMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 2(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.88E+5nMAssay Description:Inhibition of PRL2 (unknown origin) using DiFMUP as fluorogenic phosphate substrate assessed as DiFMUP dephosphorylationMore data for this Ligand-Target Pair
TargetProtein tyrosine phosphatase type IVA 2(Human)
University of Virginia Patent Foundation
US Patent
University of Virginia Patent Foundation
US Patent
Affinity DataIC50: 1.88E+5nMAssay Description:Inhibition of PRL2 (unknown origin) using DiFMUP as fluorogenic phosphate substrate assessed as DiFMUP dephosphorylationMore data for this Ligand-Target Pair
